Arjuna filed the request after the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, which ended the constitutional right to an abortion in the U.S. CVS collects sensitive information on over-the-counter reproductive health medications, such as the emergency contraceptive Plan B.
The activist investment group filed seven shareholder proposals with CVS focusing on protecting reproductive health data, according to a March 28 Arjuna news release.
“CVS is taking the steps necessary to protect its customers’ privacy and data in a post-Dobbs world,” Natasha Lamb, managing partner at Arjuna Capital, said in the release. “It’s clear that threats to women’s privacy are also a threat to CVS’s business, brand, and investors.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.